Brain tumors are stubborn cancers with poor prognosis and disappointing survival rates. Targeted cancer therapeutics with higher efficacy and lower resistance are highly demanded. An efficient one-pot synthesis of polyfunctionalized phthalazines derivatives was developed by reacting ethyl 1-aryl-5-cyano-1,6-dihydro-4-methyl-6-oxo-3-pyridazine-carboxylates with cinnamonitrile derivatives and the cycloaddition reaction of thieno[3,4-d]pyridazines with activated double or triple bond systems under controlled microwave heating with high yields. The resultant synthesized phthalazines (5a-e, 9 and 13) were tested for their in vitro anti-cancer activities by using in vitro one dose assay at National Cancer institute, USA. Only phthalazine (5b) showed broad spectrum anti-tumor activity against most tested cancer cell lines from all subpanels with mean % GI = 22.61. Interestingly, all tested compounds showed varying growth inhibitory activity against a particular cell line, CNS SNB-75 cell line, but (5b) exhibited the highest growth inhibitory activity against CNS-SNB-75 cell line with (GI% = 108.81) and (IC = 3.703 ± 0.2) compared to erlotinib; (IC = 12.5 ± 0.68). It caused Pre-G1 apoptosis and growth arrest at S phase. It also increased percentage of the total apoptotic cells in CNS-SNB-75 cell line (39.26%) compared to control cells (2.17%) in the annexin V-FITC experiment. It revealed pronounced EGFR inhibitory activity (IC = 47.27 ± 2.41 ng/mL) compared to erlotinib (IC = 30.7 ± 1.56 ng/mL). It also inhibited the different PI3K isoforms α, β, γ and δ (with IC of 4.39, 13.6, 12.5 and 3.11 μg/mL, respectively compared to LY294002 (with IC of 12.7, 8.57, 6.89 and 5.7 μg/mL, respectively). It also caused significant lower protein expression levels of pPI3K, AKT, pAKT and Bcl2 and higher protein expression levels of BAX, Casp3 and Casp9 when compared to untreated cells. Conclusion: Phthalazine (5b) may be an effective, convenient and safe anti-cancer agent acting via proapoptotic and dual EGFR and PI3K kinase inhibitory actions in CNS SNB-75 cell line.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bioorg.2022.105740 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Design, Synthesis, and Antitumor Potential of New Thiazole--contained 5-Fluoro-2-Oxindole Derivatives as Sunitinib Analogues.
Curr Med Chem
November 2024
Department of chemistry of bioactive nitrogen-containing heterocyclic bases, V. P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, Kyiv, 02094, Ukraine.
Background: Indole is considered the most promising scaffold for anticancer drug design due to its high bioavailability, unique chemical properties, and broad spectrum of pharmacological action.
Objective: Twelve novel thiazole-containing the 5-fluoro-1,3-dihydro-2H-indol-2-one derivatives as sunitinib analogs were designed and synthesized, and their anticancer activity was evaluated against the NCI-60 cancer cell lines.
Method: The thiazole-contained 5-fluoro-1,3-dihydro-2H-indol-2-one derivatives were synthesized using Knoevenagel condensation of 1,3-thiazole-5-carboxylic acid 1.
Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agents.
Bioorg Chem
October 2024
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, P.O. Box 33516, Kafrelsheikh, Egypt.
c-MET and STAT-3 are significant targets for cancer treatments. Here, we describe a class of very effective dual STAT-3 and c-MET inhibitors with coumarin-based thiazoles (3a-o) as its scaffold. Spectroscopic evidence (NMR, HRMS, and HPLC) validated the structural discoveries of the new compounds.
View Article and Find Full Text PDFNovel synthesis of the first new class of triazine sulfonamide thioglycosides and the evaluation of their anti-tumor and anti-viral activities against human coronavirus.
Nucleosides Nucleotides Nucleic Acids
December 2024
Department of Chemistry, Faculty of Science, Helwan University, Cairo, Egypt.
Novel class of triazine sulfonamide thioglycosides was designed and synthesized. Those novel structures comprising three essential and pharmacological significant moieties such as the triazine, sulfonamide, and thioglycosidic scaffolds. The triazine sulfonamides were furnished a direct approach starting from potassium cyanocarbonimidodithioate, then the corresponding triazine sulfonamide thioglycosides were generated using the peracylated -d-- and galacto-pyranosyl bromides.
View Article and Find Full Text PDFNovel Pyrimidine-5-Carbonitriles as potential apoptotic and antiproliferative agents by dual inhibition of EGFR and PI3k enzymes; Design, Synthesis, biological Evaluation, and docking studies.
Bioorg Chem
April 2024
Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo 11562, Egypt; Department of Medicinal Chemistry, Faculty of Pharmacy, Galala University, New Galala 43713, Egypt. Electronic address:
Article Synopsis
- A new series of compounds called 6-(4-fluorophenyl)-2-(methylthio)pyrimidine-5-carbonitrile derivatives were developed as dual inhibitors targeting EGFR and PI3K, showing promising results against various cancer cell lines.
- Among them, compound 7c demonstrated strong anti-tumor activity against CNS and ovarian cancers, exhibiting a much safer profile than the commonly used drug doxorubicin.
- The study indicated that compound 7c works by inducing apoptosis and affecting cell cycle progression while effectively inhibiting both EGFR and PI3K pathways, supporting its potential as a therapeutic agent.
Synthesis, Anticancer Activity, and In Silico Studies of 5-(3-Bromophenyl)--aryl-4-1,2,4-triazol-3-amine Analogs.
Molecules
October 2023
Department of Chemistry, Bihar National College, Patna 800004, Bihar, India.
In the current study, we described the synthesis of ten new 5-(3-Bromophenyl)--aryl-4-1,2,4-triazol-3-amine analogs (), as well as their characterization, anticancer activity, molecular docking studies, ADME, and toxicity prediction. The title compounds () were prepared in three steps, starting from substituted anilines in a satisfactory yield, followed by their characterization via spectroscopic techniques. The National Cancer Institute (NCI US) protocol was followed to test the compounds' () anticancer activity against nine panels of 58 cancer cell lines at a concentration of 10 M, and growth percent (GP) as well as percent growth inhibition (PGI) were calculated.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!